TORONTO, April 21, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS") and cardiovascular markets, announces that Tim Hendrickson, Chief Financial Officer, will present at the Bloom Burton & Co. Healthcare Investor Conference, which takes place Tuesday April 25 - Wednesday April 26, 2023 at the Metro Toronto Convention Centre, North Building, in downtown Toronto.
Read more at newswire.caProvided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.